Apimeds Pharmaceuticals Stock Forecast - Naive Prediction
| APUS Stock | 2.14 0.06 2.88% |
The Naive Prediction forecasted value of Apimeds Pharmaceuticals US, on the next trading day is expected to be 2.36 with a mean absolute deviation of 0.16 and the sum of the absolute errors of 10.03. Apimeds Stock Forecast is based on your current time horizon.
Total Current Liabilities is likely to gain to about 1.1 M in 2025, whereas Total Assets are likely to drop slightly above 12.4 K in 2025. Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Apimeds Pharmaceuticals' financial statements to predict how it will affect future prices.
Cash | First Reported 2010-12-31 | Previous Quarter 3.5 K | Current Value 3.3 K | Quarterly Volatility 95.4 K |
Apimeds Pharmaceuticals Naive Prediction Price Forecast For the 15th of December 2025
Given 90 days horizon, the Naive Prediction forecasted value of Apimeds Pharmaceuticals US, on the next trading day is expected to be 2.36 with a mean absolute deviation of 0.16, mean absolute percentage error of 0.06, and the sum of the absolute errors of 10.03.Please note that although there have been many attempts to predict Apimeds Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Apimeds Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Apimeds Pharmaceuticals Stock Forecast Pattern
| Backtest Apimeds Pharmaceuticals | Apimeds Pharmaceuticals Price Prediction | Buy or Sell Advice |
Apimeds Pharmaceuticals Forecasted Value
In the context of forecasting Apimeds Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Apimeds Pharmaceuticals' downside and upside margins for the forecasting period are 0.02 and 11.47, respectively. We have considered Apimeds Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Apimeds Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Apimeds Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.3325 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1644 |
| MAPE | Mean absolute percentage error | 0.0717 |
| SAE | Sum of the absolute errors | 10.0306 |
Predictive Modules for Apimeds Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Apimeds Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Apimeds Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Apimeds Pharmaceuticals
For every potential investor in Apimeds, whether a beginner or expert, Apimeds Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Apimeds Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Apimeds. Basic forecasting techniques help filter out the noise by identifying Apimeds Pharmaceuticals' price trends.Apimeds Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Apimeds Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Apimeds Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Apimeds Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Apimeds Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Apimeds Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Apimeds Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Apimeds Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Apimeds Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Apimeds Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Apimeds Pharmaceuticals stock market strength indicators, traders can identify Apimeds Pharmaceuticals US, entry and exit signals to maximize returns.
Apimeds Pharmaceuticals Risk Indicators
The analysis of Apimeds Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Apimeds Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting apimeds stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.3 | |||
| Semi Deviation | 7.11 | |||
| Standard Deviation | 9.09 | |||
| Variance | 82.65 | |||
| Downside Variance | 60.06 | |||
| Semi Variance | 50.5 | |||
| Expected Short fall | (8.24) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Apimeds Stock Analysis
When running Apimeds Pharmaceuticals' price analysis, check to measure Apimeds Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apimeds Pharmaceuticals is operating at the current time. Most of Apimeds Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apimeds Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apimeds Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apimeds Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.